Abstract
Between 2000 and 2012, the national estimated incidence rate of pediatric mastoiditis, a rare but serious complication of acute otitis media, was highest in 2006 (2.7/100,000 population) and lowest in 2012 (1.8/100,000 population). This measure provides a baseline for public health surveillance in the pneumococcal conjugate vaccine era as stewardship efforts target antibiotic use in acute otitis media.
MeSH terms
-
Acute Disease / epidemiology
-
Adolescent
-
Anti-Bacterial Agents / therapeutic use
-
Child
-
Child, Preschool
-
Female
-
Humans
-
Incidence
-
Infant
-
Male
-
Mastoiditis / epidemiology*
-
Otitis Media / complications*
-
Otitis Media / drug therapy
-
Otitis Media / epidemiology*
-
Pneumococcal Infections / epidemiology
-
Pneumococcal Vaccines / therapeutic use
-
Public Health Surveillance / methods*
-
Retrospective Studies
-
United States / epidemiology
Substances
-
Anti-Bacterial Agents
-
Pneumococcal Vaccines